MedPath
FDA Approval

Fluvoxamine maleate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 11, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fluvoxamine(25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories, LLC

079111820

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluvoxamine maleate

Product Details

NDC Product Code
0832-1670
Application Number
ANDA075888
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 31, 2023
Code: 5LGN83G74VClass: ACTIBQuantity: 25 mg in 1 1
carnauba waxInactive
Code: R12CBM0EIZClass: IACT
METHYLCELLULOSE (15 MPA.S)Inactive
Code: NPU9M2E6L8Class: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
polyethylene glycol, unspecifiedInactive
Code: 3WJQ0SDW1AClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
mannitolInactive
Code: 3OWL53L36AClass: IACT
hypromellose, unspecifiedInactive
Code: 3NXW29V3WOClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
ferric oxide yellowInactive
Code: EX438O2MRTClass: IACT

Fluvoxamine maleate

Product Details

NDC Product Code
0832-1671
Application Number
ANDA075888
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 31, 2023
Code: 5LGN83G74VClass: ACTIBQuantity: 50 mg in 1 1
magnesium stearateInactive
Code: 70097M6I30Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
carnauba waxInactive
Code: R12CBM0EIZClass: IACT
mannitolInactive
Code: 3OWL53L36AClass: IACT
hypromellose, unspecifiedInactive
Code: 3NXW29V3WOClass: IACT
METHYLCELLULOSE (15 MPA.S)Inactive
Code: NPU9M2E6L8Class: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
polyethylene glycol, unspecifiedInactive
Code: 3WJQ0SDW1AClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
ferric oxide yellowInactive
Code: EX438O2MRTClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT

Fluvoxamine maleate

Product Details

NDC Product Code
0832-1672
Application Number
ANDA075888
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 31, 2023
magnesium stearateInactive
Code: 70097M6I30Class: IACT
Code: 5LGN83G74VClass: ACTIBQuantity: 100 mg in 1 1
mannitolInactive
Code: 3OWL53L36AClass: IACT
METHYLCELLULOSE (15 MPA.S)Inactive
Code: NPU9M2E6L8Class: IACT
carnauba waxInactive
Code: R12CBM0EIZClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
polyethylene glycol, unspecifiedInactive
Code: 3WJQ0SDW1AClass: IACT
ferric oxide yellowInactive
Code: EX438O2MRTClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
hypromellose, unspecifiedInactive
Code: 3NXW29V3WOClass: IACT
ferric oxide redInactive
Code: 1K09F3G675Class: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
© Copyright 2025. All Rights Reserved by MedPath